GRAIL, Inc. (GRAL) call put ratio 1.2 calls to 1 put amid wide price movement Feb 23, 2026 05:23AM
TD Cowen on GRAIL, Inc. (GRAL): 'Study Failure A Major Setback' Feb 20, 2026 09:18AM
GRAIL, Inc. (GRAL) PT Lowered to $80 at Canaccord Genuity Feb 20, 2026 07:57AM
After-hours movers: Akamai, Opendoor, GRAIL and more Feb 19, 2026 04:34PM
GRAIL, Inc. (GRAL) Tops Q4 EPS by 157c Feb 19, 2026 04:05PM


Feb 19, 2026 04:02PM GRAIL cancer screening test reduces stage IV diagnoses in NHS trial
Feb 19, 2026 05:42AM TD Cowen Starts GRAIL, Inc. (GRAL) at Hold
Feb 17, 2026 03:35AM Baird Starts GRAIL, Inc. (GRAL) at Outperform
Jan 26, 2026 06:25AM Canaccord Genuity Reiterates Buy Rating on GRAIL, Inc. (GRAL)
Jan 14, 2026 06:34AM Canaccord Genuity Reiterates Buy Rating on GRAIL, Inc. (GRAL)
Jan 13, 2026 06:25AM Canaccord Genuity Reiterates Buy Rating on GRAIL, Inc. (GRAL)
Nov 17, 2025 06:41AM GRAIL, Inc. (GRAL) PT Raised to $105 at Canaccord Genuity
Nov 14, 2025 06:24AM GRAIL establishes $300 million at-the-market stock offering program
Nov 13, 2025 04:33PM GRAIL, Inc. (GRAL) files mixed shelf
Nov 12, 2025 04:35PM GRAIL, Inc. (GRAL) Tops Q3 EPS by 153c
Nov 12, 2025 06:45AM Guggenheim Upgrades GRAIL, Inc. (GRAL) to Buy
Oct 22, 2025 06:23AM GRAIL, Inc. (GRAL) PT Raised to $85 at Canaccord Genuity
Oct 20, 2025 11:42AM Hims & Hers CEO Dudum comments on Grail investment
Oct 20, 2025 06:01AM GRAIL study shows cancer test positive predictive value rises to 84.2%
Sep 23, 2025 09:04AM GRAIL to present data from 32,000 participants at medical conferences
Aug 12, 2025 04:03PM GRAIL, Inc. (GRAL) Tops Q2 EPS by 94c
Jun 25, 2025 04:07PM GRAIL, Inc. (GRAL) PT Raised to $38 at Morgan Stanley
Jun 18, 2025 09:01AM GRAIL, Inc. (GRAL) Announces Positive Top-Line Results From The Galleri PATHFINDER 2 Registrational Study
Jun 9, 2025 10:25AM GRAIL, Inc. (GRAL) Mentioned as Short at Ningi Research
May 14, 2025 10:23AM Increasing unusual put option volume: FND AEO FL CF EXEL TAN SATS ARCC NEXT GRAL NMM URA
May 14, 2025 04:32AM GRAIL, Inc. (GRAL) PT Raised to $43 at Canaccord Genuity, 'We believe the shares do not reflect the company's growth potential'
May 13, 2025 04:56PM After-hours movers: American Eagle Outfitters, Aurora, GRAIL
May 13, 2025 04:03PM GRAIL, Inc. (GRAL) Tops Q1 EPS by $1.16
May 12, 2025 04:01PM GRAIL (GRAL) and athenahealth Team Up to Offer Healthcare Providers Streamlined Ordering of GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test
Apr 21, 2025 06:22AM Canaccord Genuity Starts GRAIL, Inc. (GRAL) at Buy
Feb 25, 2025 09:12AM GRAIL, Inc. (GRAL) partners with Kate Walsh to launch Generation Possible
Feb 20, 2025 04:25PM GRAIL, Inc. (GRAL) Reports Q4 Loss of $2.89
Nov 27, 2024 03:59AM Morgan Stanley Starts GRAIL, Inc. (GRAL) at Equalweight
Nov 12, 2024 04:33PM GRAIL, Inc. (GRAL) Reports Q3 Loss of $3.94
Oct 21, 2024 04:01PM GRAIL (GRAL) Appoints Sarah Krevans to its Board
Aug 29, 2024 04:17PM GRAIL, Inc. (GRAL): Results of Galleri Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology
Aug 13, 2024 04:11PM GRAIL, Inc. (GRAL) Reports Q2 Loss of $51.06/sh
Jun 24, 2024 04:06PM GRAIL (GRAL) to Commence Separate Trading on Nasdaq